Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginger's Therapeutic Potential in Asthma
NCT07792395Phase 2Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ginger extract in asthma (4 arms). Primary endpoint: PD20 dose of methacholine at 56 days. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
ginger extract
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07792395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07792395.